SAN FRANCISCO--(BUSINESS WIRE)--AliveCor, Inc. today announced that the AliveCor Heart Monitor is now being offered to participants in the Health eHeart Study with 2,000 units to be deployed before the end of the year. The University of California San Francisco’s (UCSF) Health eHeart Study aims to enroll 1 million participants and monitor heart health for at least 10 years.
The goal of the study is to better understand which factors impact heart health long-term, and thereby develop better methods to predict, prevent and treat cardiovascular disease.
“The Health eHeart study uses mobile technology to help gather data and personalize the way we prevent and manage heart disease,” said Euan Thomson, CEO and President of AliveCor. “The AliveCor Heart Monitor is a natural fit for the study. We are delighted to be supporting UCSF in their ground-breaking research.”
The AliveCor Heart Monitor is the only mobile ECG device that supports both iPhone and Android compatible smartphones. It records, displays, annotates, stores, and transfers single-channel electrocardiogram (ECG) rhythms wirelessly, using the free AliveECG app. Overall ease of use and convenience is further expanded with AliveInsights for tracking of heart rate and the Enhanced Filter that improves visual output of the ECG. Over 300,000 ECGs have been recorded to date with the Heart Monitor. With secure storage in the Cloud, patients can access their data confidentially any time, anywhere, and can grant access to their physician.
“The goal of Health eHeart Study is to expand on traditional research studies, which have identified common risk factors for heart disease by studying several thousand people with yearly or biannual visits to the clinic for tests and examination, such as an ECG,” said Jeffrey Olgin, MD, chief of UCSF Division of Cardiology, and one of the principal investigators of the Health eHeart Study. “The Health eHeart Study expands on these types of studies by being able to track participants anywhere in the world and receive data any time they choose to send their information. The AliveCor Heart Monitor helps us collect ECG data on large numbers of people and at much more frequent intervals simply through their smartphone.”
The AliveCor Heart Monitor is available for purchase in the United States to medical professionals and patients with prescriptions. To learn more, please visit www.alivecor.com.
AliveCor, Inc., a privately held company headquartered in San Francisco, believes everyone should have their health at their fingertips. The company plans to make the vital health signs of people around the globe easily visible and actionable, at exceptionally low cost. This has the potential to improve everything from public health to the lives of individual people all over the world.
For those interested in more information, please visit www.AliveCor.com, follow us on Twitter @AliveCor, on Facebook at facebook.com/alivecor and view our videos at youtube.com/alivecor.
AliveCor is a trademark of AliveCor, Inc. in the U.S. and other countries. iPhone® is a trademark of Apple Inc., registered in the U.S. and other countries. Android is a trademark of Google Inc.
